Merck KGaA is operating in the pharmaceutical and chemical business sectors. The Pharmaceuticals business sector comprises innovative prescription drugs as well as over-the-counter products, and operates through three division: Merck Serono, which markets products used in oncology and treatment of autoimmune and inflammatory diseases, among others, Consumer Health Care, which markets products for everyday health protection and mobility, among others and Clinical Trials, engaged in conducting clinical trails. The Chemicals business sector offers specialty products for the electronics, printing, coatings, cosmetics, food, pharmaceutical and biotech industries. The Chemicals division markets Liquid Crystals and Performance & Life Science Chemicals. As of December 31, 2009, it had subsidiaries in Germany, Switzerland, Italy, the United Kingdom, the United States, Brazil and Japan, among others. In July 2010, the Company acquired Millipore Corporation.
About Merck Millipore
Merck Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers’ success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, Merck Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 66 countries and 2013 revenues of €2.6 billion. Merck Millipore operates as EMD Millipore in the U.S. and Canada.
Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany
Merck Invests in Expansion of Manufacturing Capacity for Biotech Medicines
€150 million investment over the 2019-2023 period in manufacturing site at Aubonne, Switzerland. Expansion supports growth of current and future portfolio of Merck’s biotech medicines for patients ...
Merck Millipore Expands Manufacturing Capabilities in France with €12 Million Investment
Investment to expand Ready-To-Use Media manufacturing. Included Innovation Center to support and develop anticipated customer needs.
Merck to Invest € 50 Million in Italian Production Site in Bari
Investment to meet the rising demand for biopharmaceuticals